Manufacturing and Production

Showing 15 posts of 5879 posts found.

pharma_pill_manufacturing

Jazz Pharmaceuticals UK supplier hit with FDA warning

January 26, 2017 Manufacturing and Production Erwinaze, Porton Biopharma, jazz pharmaceuticals

UK-based Porton Biopharma, supplier of Irish company Jazz Pharmaceuticals’ leukaemia treatment Erwinaze, has been slapped with an FDA warning letter …
regeneron

Regeneron agrees ownership of HQ for $720m after 25 years

January 25, 2017 Manufacturing and Production, Medical Communications Regeneron

After leasing the property for 25 years, Regeneron has agreed to take ownership of its headquarters and buy the Landmark …
peter_wheatley_price

Takeda UK names new market access director

January 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda

Takeda UK has appointed Peter Wheatley Price to the role of market access director, where he will also sit on …

Indian pharma firm caught shredding documents at 1am by FDA

January 24, 2017 Manufacturing and Production, Research and Development FDA, Hetero Labs, observations

Hetero Labs, an Indian pharmaceutical firm, has been observed by the FDA shredding what the FDA judged to be controlled …
abbvie_0

EMA Accelerated Assessment for AbbVie’s hepatitis C regimen

January 24, 2017 Manufacturing and Production, Research and Development AbbVie, EMA, hepatitis C

AbbVie has announced that its investigational, pan-genotypic regimen of Glecaprevir/Pibrentasvir has been awarded Accelerated Assessment by the European Medicines Agency …
phrma_logo

US Pharma launches multi-million dollar media campaign to deflect pricing criticism

January 24, 2017 Manufacturing and Production, Medical Communications PhMRA, Trump

In response to a number of recent criticisms over pricing including president Trump’s message that pharma companies are “getting away …
roche_close

Roche’s Actemra granted Priority Review by FDA

January 24, 2017 Manufacturing and Production, Sales and Marketing Actemra, FDA, Roche, priority review

Roche’s drug, Actemra (also known as RoActemra in Europe), has been granted priority review designation by the FDA for the …
computer_doctor

Thinking big data

January 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, IBM Watson Health, ibm

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …
kaleo

Rival to EpiPen to be made available to many for free

January 23, 2017 Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival

Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …
shutterstock_206748499

Centre for Process Innovation to support pharma SMEs

January 17, 2017 Manufacturing and Production, Medical Communications, Research and Development CPI, Centre for Process Innovation

The Centre for Process Innovation is targeting small and medium-sized enterprises from the pharmaceutical and chemical industries with its Innovation …
janssen_latest_logo_on_sign_closer

SMC rejects Janssen’s multiple myeloma treatment Darzalex

January 17, 2017 Manufacturing and Production, Sales and Marketing Janssen, SMC, darzalex

The Scottish Medicines Consortium (SMC) has decided not to recommend Janssen’s Darzalex (daratumumab) for routine use by NHS Scotland as …
mr058666-web

Merck forges data analytics partnership with Palantir

January 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Merck, Palantir

Merck has teamed up with software and data-mining firm Palantir with the intention to utilise its data analytics services to …

AZ to rework ongoing immuno-oncology trials to “enhance options”

January 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, non-small cell lung cancer

Due to the “strong efficacy” shown by its durvalumab as a treatment for non-small cell lung cancer (NSCLC), AstraZeneca has …
The Gateway to Local Adoption Series

Latest content